Uroflowmetry Curve Types and IPSS in Men With LUTS
NCT07016776 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2025-09-03
Summary
This prospective observational study aims to evaluate the relationship between different uroflowmetry curve types and International Prostate Symptom Score (IPSS) domains in men presenting with lower urinary tract symptoms (LUTS). Participants will undergo routine clinical evaluations including uroflowmetry, laboratory assessments, and completion of the IPSS questionnaire.
Each participant will be classified into one of five predefined uroflowmetry curve types (normal/bell-shaped, plateau, staccato, intermittent, or tower-like). The IPSS will be analyzed both as a total score and as two subdomains: storage and voiding symptoms. Additional data such as age, comorbidities, medication use, prostate volume, eGFR, and QoL score will also be recorded to assess potential correlations and predictive factors for symptom severity.
The goal of this study is to better understand how objective urodynamic findings correlate with patient-reported symptoms and to inform clinical decision-making in men with LUTS.
Conditions
- Lower Urinary Tract Symptoms (LUTS)
- Benign Prostatic Hyperplasia (BPH)
- Voiding Dysfunction
Sponsors & Collaborators
-
Tarik Emre Sener
lead OTHER
Eligibility
- Min Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-15
- Primary Completion
- 2025-10-30
- Completion
- 2026-06-15
More Related Trials
-
Real World Data on Management of Male LUTS
NCT03075449 ·Status: COMPLETED
-
Identification and Treatment of Men With BPH in the Primary Care Setting
NCT00211640 ·Status: COMPLETED
-
Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years
NCT02757963 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues
NCT02542501 ·Status: COMPLETED
-
The Association of Baseline Characteristics of Male Patients Presented With LUTS and Long Term Clinical Outcomes
NCT04764903 ·Status: COMPLETED
-
The Value of Multiple Urine Flow Rate Measurements in Male Benign Prostatic Hyperplasia (BPH) Subjects
NCT00710749 ·Status: COMPLETED ·Phase: NA
-
Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
NCT06051383 ·Status: COMPLETED ·Phase: NA
-
Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH
NCT03179670 ·Status: COMPLETED
-
Chronic Prostatitis/Chronic Pelvic Pain Syndrome Patients
NCT06016595 ·Status: COMPLETED
-
Prevalence of Bacteriuria, Antibiotic Susceptibility, and Treatment Response in Symptomatic Benign Prostatic Hyperplasia
NCT06520267 ·Status: COMPLETED
-
High Intensity Focused Ultrasound (HIFU) Ablation for Treatment of Prostate Tissue in Bladder Outlet Obstruction
NCT07194187 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Evaluate the Effects of a Prostate Health Formulation
NCT02886832 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)
NCT02167919 ·Status: COMPLETED ·Phase: NA
-
The Predictive Value of Prostate Spherical Volume Ratio in Lower Urinary Tract Symptoms and Clinical Progression of Benign Prostatic Hyperplasia:A Single-center Paired Validating Confirmatory Study
NCT06448533 ·Status: COMPLETED
-
Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH
NCT05757687 ·Status: RECRUITING ·Phase: NA
-
Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS)
NCT01250483 ·Status: COMPLETED
-
Efficacy of Prostate Seed Implantation for Local Control of Early Stage Prostate Cancer
NCT00773305 ·Status: COMPLETED
-
Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 Grams
NCT02167009 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Self-administered IPSS, Sanitary Staff-supervised IPSS, Medical History and Clinical Parameters
NCT03603821 ·Status: UNKNOWN
-
Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms
NCT01457573 ·Status: COMPLETED ·Phase: PHASE4
-
Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients
NCT01736033 ·Status: UNKNOWN ·Phase: PHASE4
-
Prostatic Artery Embolization vs. Pharmacotherapy for LUTS/BPH
NCT04245566 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Prostate Artery Embolization: Single Center Experience
NCT04766268 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
NCT02757768 ·Status: COMPLETED ·Phase: PHASE4
-
Bladder and Prostate Sonomorphology in Patients With Symptomatic Benign Prostatic Hyperplasia
NCT04352257 ·Status: UNKNOWN